BMJ 'Under Review': What Each Status Means and When to Expect a Decision

Before the paper reaches external reviewers, a BMJ handling editor evaluates whether the work warrants external review at The BMJ. Desk rejection typically arrives within 5 to 7 days. A desk rejection most often means the BMJ handling editor concluded that the work would fit better at a sister BMJ journal (BMJ Open for clinical-research open-access cascade, BMJ specialty journals for specialty scope) or that the general-medicine relevance bar is not met.

About 70 percent of submissions are rejected at the editor stage; total desk rejection (including post-statistical-review desk rejection) reaches 80 to 85 percent.

The BMJ editorial office checks a smaller, higher-stakes package than most broad medical journals: a research manuscript built around a clinical decision, embedded figures where required, the correct EQUATOR checklist, protocol or trial-registration evidence, author-contribution statements, patient and public involvement language when relevant, competing-interest declarations, ethics approval, and data-sharing commitments. For research articles submitted from January 1, 2026, BMJ also lists an open-access fee of £6080 / €7270 / $8090 on acceptance, so authors should confirm funder or institutional coverage while the paper is still active.

The BMJ handling editor reads the paper and evaluates general-medicine relevance, methodological rigor, and BMJ family routing.

In parallel with the handling editor's primary read, the BMJ clinical epidemiology editor evaluates statistical methodology for quantitative papers. The clinical epidemiology editor's review focuses on study design, sample-size justification, multiple-testing adjustments, and missing-data handling. This clinical-epidemiology-editor review runs alongside the handling editor's read and adds 3 to 14 days to the timeline that is invisible to the author in the portal.

BMJ handling editors typically invite 2 to 3 clinical experts plus a statistical reviewer. The recruitment window can take 7 to 14 days because BMJ recruits topic-matched general-medicine reviewers plus statistical reviewers, and the open peer review system means reviewers' names will be disclosed to authors.

Once reviewers agree to review, the typical BMJ peer-review cycle lasts 2 to 6 weeks per reviewer. The BMJ operates open peer review: authors are told who reviewed their manuscript, and reports are published alongside accepted papers. Reviewers are asked to evaluate general-medicine relevance, methodological rigor, statistical methodology, and reproducibility.

The next step for your research article, after peer review and assessment by the BMJ's clinical epidemiology editor, is full appraisal at the weekly manuscript committee meeting, where a statistician, an external editorial adviser, your paper's editor, and the BMJ research team will read and discuss your article's importance, originality, and scientific quality and the editor will make the final decision.

• Rejection within 1 to 5 days: Administrative issue or immediate scope mismatch.

• Rejection within 5 to 21 days: BMJ handling editor desk rejection per the 70 to 85 percent figure.

• Still Under Review after 3 weeks: Strong signal. Paper passed the BMJ editor filter.

• Still Under Review after 12 weeks: Reviewer-recruitment or weekly committee meeting cycle delay. A polite inquiry via the ScholarOne portal is appropriate.

• Status changes to "At Manuscript Committee": Reports are in; expect a decision within 1 to 2 weeks of the next weekly meeting.

This is the most common anxiety we hear from BMJ authors during the active editorial window. The honest answer: no, 8 weeks at Under Review puts you in the normal middle of The BMJ's 6 to 12 week post-screen first-decision distribution. Reports may already be in editorial synthesis with your paper's editor preparing for the next weekly manuscript committee meeting.

Most reviewer-driven delays come from reviewer-recruitment timing rather than slow reviews because The BMJ recruits topic-matched general-medicine reviewers plus statistical reviewers under an open peer review model. If the portal still says Under Review at the 12-week mark, the most likely explanation is that one of the assigned reviewers asked for an extension or that the weekly manuscript committee meeting cycle slipped due to scheduling.

This is normal practice at The BMJ.

What you should NOT do during the 8-to-12-week window is email the editorial office. BMJ handling editors are managing 30+ active papers; an inquiry at 8 weeks adds friction without accelerating the timeline.

• Do not email the editorial office during the first 6 weeks unless an urgent ethics issue surfaces.

• Do not submit the paper anywhere else while it is Under Review at The BMJ. The BMJ has explicit prohibitions on dual submission.

• Prepare a point-by-point response template for likely reviewer concerns: general-medicine relevance, statistical rigor, CONSORT compliance, reproducibility. Anticipate that reports will be public under open peer review.

• If you have related work submitted elsewhere or recently published, prepare disclosure language for when revisions are requested.

• Read recent BMJ research articles in your subfield to calibrate the current editorial bar.

If your BMJ paper is rejected after review, the natural cascade depends on what the reviewers and editor cited:

BMJ Open is the natural BMJ open-access cascade for clinical-research papers where the general-medicine relevance bar of The BMJ is not met but the rigor is high. BMJ supports manuscript-transfer with reviewer reports preserved.

BMJ specialty journals (Heart, Gut, Thorax, Annals of the Rheumatic Diseases, etc.) are BMJ cascades where the specialty editorial scope fits.

NEJM is the external general-medicine cascade for top-tier evidence-changes-practice clinical-research. NEJM uses ScholarOne at ScholarOne submission portal; editorial contact nejm@nejm.org.

The Lancet is the external general-medicine cascade for top-tier global-clinical-impact work. The Lancet uses Editorial Manager at Editorial Manager submission portal; editorial contact editorial@lancet.com.

JAMA is the AMA general-medicine cascade. JAMA uses ScholarOne at ScholarOne submission portal; editorial contact jama-editor@jamanetwork.org.

The BMJ asks reviewers to evaluate four things specifically. The table below maps each to actionable preparation.

Across BMJ-targeted manuscripts, three named patterns generate the most consistent reviewer concerns and the most common reasons an "Under Review" status later turns into rejection, major revision, or BMJ Open transfer. The BMJ editors first ask whether the paper matters to a broad clinical readership. Reviewers and statistical editors then test whether the methods, reporting checklist, patient relevance, and data-sharing story can support that claim.

Specialty-only framing is flagged at the BMJ editor screen. When the title, introduction, and abstract frame the work as a narrow specialty result without general-medicine readership relevance, BMJ editors often decide the paper belongs in a specialty journal or BMJ Open. The strongest BMJ manuscripts make a practicing clinician understand the decision consequence in the first page. If your first screen still reads like a specialist paper, run a Check whether your BMJ clinical relevance is clear → before the committee conversation.

Statistical methodology gaps surface before or during review. When statistical methods documentation is thin, especially sample-size justification, multiple-testing adjustments, missing-data handling, subgroup analysis, model selection, or sensitivity analysis, BMJ statistical review consistently flags concerns. The strongest revisions include pre-registration documentation, an analysis-plan crosswalk, table shells that match the protocol, and a clear explanation of deviations. If this is the weak point, use a Check your BMJ statistical-methods package → while the paper is still under review.

BMJ Open or specialty cascade language usually signals fit, not uselessness. When the handling editor concludes the work is rigorous but below The BMJ's general-medicine bar, transfer offers to BMJ Open or a specialty BMJ journal are common. In the manuscripts we review, this pattern usually appears when the evidence is credible but the cover letter, abstract, and discussion do not explain why the result changes practice across specialties.

The right preparation is a transfer-ready response file that preserves reviewer work and reframes the manuscript for the receiving journal. If you need that fallback mapped now, run a Check whether your BMJ fallback route is ready →.

This page helps BMJ authors decide whether to prepare a revision, tighten the statistical package, or plan a BMJ Open cascade while the portal is quiet. It tells you what BMJ editors look for while the manuscript is being routed or reviewed. The review tells you whether your paper passes that check before the decision arrives.

Manusights review data from BMJ and adjacent clinical-journal manuscripts shows these failure patterns repeatedly; in practice, we see committee-readiness and statistics alignment matter more than the visible ScholarOne label. 60-day money-back guarantee. We do not train AI on your manuscript and delete it within 24 hours.

This page was created from The BMJ's public editorial documentation at Bmj source page, BMJ Author Hub tracking and review-process guidance, BMJ editorial process documentation (80 to 85 percent desk rejection within 5 to 7 days, 6 to 12 week post-screen first decision, ~48-day median with peer review, 2 to 3 clinical experts plus statistical reviewer, weekly manuscript committee meeting model, open peer review system), SciRev community data where available, and Manusights pre-submission review experience with BMJ-targeted manuscripts.

Official guidance covers the visible workflow; the Manusights sections add status-anxiety interpretation from recent BMJ-style manuscripts where reviewers focused on general-medicine relevance, statistics, reporting checklists, and cascade fit. Source limitation: BMJ public tracking explains where a paper is in ScholarOne, but not whether the next risk is clinical relevance, statistics, or manuscript-committee priority.

For the BMJ general-medicine landscape beyond The BMJ flagship, see BMJ Open (open-access cascade), BMJ specialty journals (Heart, Gut, Thorax, Annals of the Rheumatic Diseases for specialty editorial scope), and external general-medicine alternatives (NEJM, Lancet, JAMA, Annals of Internal Medicine).

The choice across these titles depends on whether the central contribution is top-tier general-medicine (The BMJ), BMJ open-access clinical-research (BMJ Open), specialty BMJ scope (BMJ specialty journals), top-tier evidence-changes-practice (NEJM), top-tier global-clinical-impact (Lancet), AMA general-medicine (JAMA), or internal-medicine clinical-research (Annals of Internal Medicine).

Reviewers at The BMJ typically draw from 2 to 3 clinical specialists plus a statistical reviewer. Editors screen and triage manuscripts before any external reviewer sees them, with the clinical epidemiology editor providing an additional layer of methodology evaluation. The weekly manuscript committee meeting is a distinctive BMJ feature that ensures multi-perspective final decisions. Preparing a response template that addresses general-medicine relevance, statistical methodology, and CONSORT compliance accelerates revision rounds substantially.

For a pre-upload check of your manuscript against the BMJ general-medicine-relevance-plus-weekly-committee bar before submission, our BMJ pre-submission diagnostic flags the framing and CONSORT-compliance weaknesses most likely to surface in reviewer reports.